Ibandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis.

J Riis, B; Ise, J; von Stein, T; Bagger, Y; Christiansen, C

doi:10.1359/jbmr.2001.16.10.1871

Public

Ibandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis.

Shared by NobleBlocks on Oct 1, 2001 • 12:00 AM UTC

Authors:

B J Riis

J Ise

T von Stein

Abstract

The objective of this study was to compare efficacy and safety of continuous versus intermittent oral dosing of ibandronate. Two hundred forty women aged 55-75 years with postmenopausal osteoporosis were randomized to active treatment or placebo. Similar total doses of ibandronate were provided by t...

Discussions